Sign in

CIK 0001070494 · Large accelerated filer

ACADIA PHARMACEUTICALS INC

Sign in to watch
Ticker
ACAD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
061376651
Phone
858-558-2871
Business address
12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. 4 Option exercise Director acquired 4,381 shares (option exercise)
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. S-8 Other Securities Offered to Employees in Benefit Plans
  7. 8-K Event Executive or director change
  8. 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 9,733 shares at $15.28 ($148,720)
  9. 4 Open-market sale EVP, COO, HEAD OF COMMERCIAL sold 9,534 shares at $15.28 ($145,680)
  10. 4 Open-market sale CEO sold 31,747 shares at $15.28 ($485,094)
  11. S-8 POS Other Post-effective Amendment
  12. S-8 POS Other Post-effective Amendment
  13. S-8 POS Other Post-effective Amendment
  14. S-8 POS Other Post-effective Amendment
  15. S-8 POS Other Post-effective Amendment
  16. S-8 POS Other Post-effective Amendment
  17. S-8 POS Other Post-effective Amendment
  18. S-8 POS Other Post-effective Amendment
  19. S-8 POS Other Post-effective Amendment
  20. 4 Derivatives Options or other derivatives

Page 7 of 70 · 1,382 filings